InspireMD Inc Asset Resilience Ratio
InspireMD Inc asset resilience ratio. InspireMD Inc (NSPR) has an Asset Resilience Ratio of 34.21% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See InspireMD Inc (NSPR) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of InspireMD Inc (2011–2025)
Asset resilience ratio of InspireMD Inc from 2011 to 2025. This chart shows how InspireMD Inc's Asset Resilience Ratio has changed over time. Read NSPR total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down InspireMD Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of InspireMD Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $15.27 Million | 34.21% |
| Total Liquid Assets | $15.27 Million | 34.21% |
Asset Resilience Insights
- Very High Liquidity: InspireMD Inc maintains exceptional liquid asset reserves at 34.21% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
InspireMD Inc Industry Peers by Asset Resilience Ratio
Compare InspireMD Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
InspireMD Inc Asset Resilience Ratio by Year (2011–2025)
InspireMD Inc asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for InspireMD Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 65.23% | $45.27 Million | $69.40 Million | +31.64pp |
| 2024-12-31 | 33.59% | $15.72 Million | $46.81 Million | -28.09pp |
| 2023-12-31 | 61.67% | $29.38 Million | $47.64 Million | +8.25pp |
| 2022-12-31 | 53.43% | $13.17 Million | $24.65 Million | -2.06pp |
| 2021-12-31 | 55.49% | $22.04 Million | $39.71 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $17.78 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $6.11 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $9.41 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $5.78 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $11.46 Million | -- |
| 2012-12-31 | 0.58% | $93.00K | $16.01 Million | +0.35pp |
| 2012-06-30 | 0.23% | $37.00K | $16.01 Million | -0.34pp |
| 2011-12-31 | 0.57% | $91.00K | $16.01 Million | -- |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more